Announce Date | 04/23/2025 |
EPS Normalized Actual | $0.87 (Miss by $-0.05) |
EPS GAAP Actual | $0.87 (Miss by $-0.05) |
Revenue Actual | $1.801B |
Revenue Surprise | Beat by $1801M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.30324 |
EPS GAAP Estimate | $1.30324 |
Revenue Estimate | $2.172085204B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 5.99771 | 11.22 | 5.91388 | 6.10852 | 1 |
Dec 2026 | 5.02719 | 13.38 | 4.9 | 5.09875 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0 | -1.03717 | 1.801B | -6.94% | -197.27M |
FQ4 2024 (Dec 2024) | 0.85 | 0.85 | 1.828B | -2.95% | 1828M |
FQ3 2024 (Sep 2024) | 0.76 | 0.76 | 1.983B | 0.2% | 1983M |
FQ2 2024 (Jun 2024) | 1.18 | 1.18 | 2.091B | -1.72% | 2091M |
FQ1 2024 (Mar 2024) | 0 | 0 | 1.926B | -2.75% | 1926M |
FQ4 2023 (Dec 2023) | 0.87 | 0.87 | 1.882B | -2.18% | 1882M |
FQ3 2023 (Sep 2023) | 1.11 | 1.11 | 1.979B | -11.37% | 1979M |
FQ2 2023 (Jun 2023) | 1.17 | 1.17 | 2.127B | -10.58% | 2127M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.30324
Consensus Revenue Estimates
2.172085204B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.45 | -- | 1.41822 | 1.48202 | 8 |
FQ2 2027 (Jun 2027) | 1.51 | -- | 1.47691 | 1.54335 | 5 |
FQ1 2027 (Mar 2027) | 1.17 | -- | 1.14436 | 1.19584 | 4 |
FQ4 2026 (Oct 2026) | 1.29 | -- | 1.26666 | 1.32171 | 9 |
FQ3 2026 (Jul 2026) | 1.375 | -- | 1.35012 | 1.4088 | 9 |
FQ2 2026 (Jun 2026) | 1.45657 | -- | 1.42663 | 1.48512 | 9 |
FQ1 2026 (Mar 2026) | 1.08834 | -- | 1.06597 | 1.10967 | 9 |
FQ4 2025 (Oct 2025) | 1.2253 | 30.63 | 1.20313 | 1.25542 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2.14B | -- | 2.1B | 2.17B | 4 |
FQ2 2027 (Jun 2027) | 2.25B | -- | 2.21B | 2.29B | 6 |
FQ1 2027 (Mar 2027) | 2.05B | -- | 2.01B | 2.08B | 4 |
FQ4 2026 (Oct 2026) | 2.16B | -- | 2.13B | 2.2B | 10 |
FQ3 2026 (Jul 2026) | 2.24B | -- | 2.21B | 2.29B | 10 |
FQ2 2026 (Jun 2026) | 2.32B | -- | 2.28B | 2.36B | 10 |
FQ1 2026 (Mar 2026) | 2.13B | 15.44 | 2.1B | 2.16B | 10 |
FQ4 2025 (Oct 2025) | 2.1B | 13.03 | 2.07B | 2.14B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.03717 | 0 | -1.03717 | -INF% |
FQ4 2024 (Dec 2024) | 0.85 | 0.85 | 100% | |
FQ3 2024 (Sep 2024) | 0.76 | 0.76 | 100% | |
FQ2 2024 (Jun 2024) | 1.18 | 1.18 | 100% | |
FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Dec 2023) | 0.87 | 0.87 | 100% | |
FQ3 2023 (Sep 2023) | 1.11 | 1.11 | 100% | |
FQ2 2023 (Jun 2023) | 1.17 | 1.17 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $2B | $1.8B | $-197.27M | -10.95% |
FQ4 2024 (Dec 2024) | $0B | $1.83B | $1828M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.98B | $1983M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.09B | $2091M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.93B | $1926M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.88B | $1882M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.98B | $1979M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.13B | $2127M | 100% |